Trials / Unknown
UnknownNCT04084613
Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Attikon Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective multi-centre, non-interventional observational study, that will be conducted in several centers in Greece for a 2-year time period (completion date December 2020), to describe patient characteristics, medical history, and the clinical benefit of mepolizumab in patients with severe eosinophilic asthma newly initiated to the drug.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-09-10
- Last updated
- 2019-09-12
Source: ClinicalTrials.gov record NCT04084613. Inclusion in this directory is not an endorsement.